SCIENTURE HOLDINGS, INC. Proceeds from Issuance of Convertible Preferred Stock
SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from Issuance of Convertible Preferred Stock of $2.95 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. proceeds from issuance of convertible preferred stock for fiscal 2024 was $2.95M.
- SCIENTURE HOLDINGS, INC. proceeds from issuance of convertible preferred stock for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- SCIENTURE HOLDINGS, INC. proceeds from issuance of convertible preferred stock for fiscal 2014 was $10.00.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 12 month |
|---|---|
| 2024-12-31 | $2.95M 10-K · filed 2026-03-30 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-28 |
| 2014-12-31 | $10.00 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |